Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
- Sponsor
- Sen. Alsobrooks, Angela D. [D-MD]
- Committees
- Health, Education, Labor, and Pensions Committee (primary)
- Last action
- Mar 19, 2026
Bottom line
The bill aims to improve health outcomes for individuals with uterine fibroids and related conditions by funding federal research, developing evidence-based strategies, and supporting state-level early detection, intervention, and public awareness programs.
What it actually does
This bill authorizes the Secretary of Health and Human Services (HHS) to conduct and support research on increasing early detection and intervention for uterine fibroids, and to formulate evidence-based strategies. It also authorizes HHS to award grants to states for programs aimed at increasing early detection, intervention, and public awareness regarding uterine fibroids, including funding for screening and patient navigation. Additionally, it allows for grants to states for research, including clinical trials, on disparities in pain management during uterine fibroid surgery and other intrauterine conditions.
Proponents argue
Supporters argue that this bill addresses a significant public health issue affecting a large number of individuals, particularly women, by promoting critical research, improving early detection, and facilitating access to intervention. They contend that the focus on evidence-based strategies and addressing disparities in pain management will lead to more effective and equitable care for uterine fibroids and related gynecological conditions.
Opponents contend
Potential critics might raise concerns about the financial implications of authorizing new grant programs without specifying a dedicated funding mechanism or offsetting costs, suggesting it could contribute to federal spending without clear fiscal responsibility. Some might also question the extent of federal involvement in health issues that could be managed at the state or local level, or through existing private sector initiatives.
The bill is concise and clearly written, making it accessible for a quick and thorough evaluation by any interested reader.
Section 2
HHS Research and Strategy Development for Uterine Fibroids
This section directs the Secretary of Health and Human Services to either conduct or support research focused on improving the early detection and intervention methods for uterine fibroids. Based on the findings from this research, the Secretary is required to develop and finalize evidence-based or evidence-informed strategies to enhance early detection within healthcare settings. These strategies are intended to be made available expeditiously to states that receive grants under Section 3 for implementation.
Supporters argue
Supporters argue that robust, federally supported research is essential for advancing medical understanding and developing effective public health interventions. They contend that evidence-based strategies are crucial for ensuring that early detection efforts are effective and lead to better patient outcomes.
Critics contend
No specific opposition is typically raised against funding medical research, though some might argue for broader research priorities or question the efficiency of federal involvement versus private sector research.
Tradeoffs
Allocating federal resources to this specific research area means those resources are not available for other health research priorities. However, proponents emphasize the significant public health burden of uterine fibroids justifies this focus.
Section 3
State Grant Program for Uterine Fibroid Early Detection and Public Awareness
This section authorizes the Secretary of HHS to award grants to states. These grants are specifically for carrying out programs designed to increase early detection and intervention for uterine fibroids, and to develop and implement public awareness and education campaigns. States receiving these funds can use them for various activities, including screening procedures (such as advanced gynecological imaging and covering associated costs), patient navigation services, implementing the evidence-based strategies developed under Section 2, and facilitating access to healthcare settings.
Section 4
State Grants for Specific Uterine Fibroid and Related Condition Research
This section authorizes the Secretary of HHS to award additional grants to states, specifically for conducting research, which may include clinical trials. The research areas targeted are disparities in pain control and management during uterine fibroid surgical treatment, and other intrauterine conditions such as Asherman's Syndrome and intrauterine adhesions, as deemed appropriate by the Secretary. This aims to deepen understanding and improve treatment for these specific, often overlooked, aspects of gynecological health.